Pheton Holdings Ltd (NASDAQ:PTHL) Sees Significant Decrease in Short Interest

by · The Cerbat Gem

Pheton Holdings Ltd (NASDAQ:PTHL – Get Free Report) saw a significant decrease in short interest in the month of December. As of December 31st, there was short interest totaling 17,067 shares, a decrease of 29.4% from the December 15th total of 24,161 shares. Approximately 0.3% of the company’s shares are short sold. Based on an average daily volume of 68,493 shares, the short-interest ratio is presently 0.2 days. Based on an average daily volume of 68,493 shares, the short-interest ratio is presently 0.2 days. Approximately 0.3% of the company’s shares are short sold.

Pheton Price Performance

NASDAQ:PTHL opened at $0.92 on Friday. The business’s fifty day moving average price is $0.54 and its 200 day moving average price is $3.63. Pheton has a 12 month low of $0.39 and a 12 month high of $32.00.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on PTHL shares. Weiss Ratings restated a “sell (e+)” rating on shares of Pheton in a report on Friday, October 31st. Wall Street Zen upgraded shares of Pheton from a “sell” rating to a “hold” rating in a research note on Sunday, September 21st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Pheton has a consensus rating of “Sell”.

Check Out Our Latest Report on PTHL

About Pheton

(Get Free Report)

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.

Featured Articles